Last reviewed · How we verify
Universidad Abierta Interamericana — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Dextrose 5% (D5W) | Dextrose 5% (D5W) | marketed | Intravenous fluid / Carbohydrate solution | Supportive Care / Fluid and Electrolyte Management |
Therapeutic area mix
- Supportive Care / Fluid and Electrolyte Management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Dr. Dean Reeves Clinic · 1 shared drug class
- University of Michigan · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Universidad Abierta Interamericana:
- Universidad Abierta Interamericana pipeline updates — RSS
- Universidad Abierta Interamericana pipeline updates — Atom
- Universidad Abierta Interamericana pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Universidad Abierta Interamericana — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-abierta-interamericana. Accessed 2026-05-16.